Changing aspirin use in patients with Type 2 diabetes in the UKPDS

Aims  To examine the proportion of UK Prospective Diabetes Study (UKPDS) patients with Type 2 diabetes taking aspirin regularly for the primary and secondary prevention of cardiovascular disease (CVD) before and after publication of the 1997 American Diabetes Association (ADA) Clinical Practice Reco...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 2004-12, Vol.21 (12), p.1368-1371
Main Authors: Cull, C. A., Neil, H. A. W., Holman, R. R.
Format: Article
Language:English
Subjects:
Age Distribution
Aged
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
aspirin
Aspirin - therapeutic use
Biological and medical sciences
cardiovascular disease
Cardiovascular Diseases - prevention & control
Diabetes Mellitus, Type 2 - drug therapy
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Female
Guideline Adherence
Humans
Male
Medical sciences
Middle Aged
Sex Distribution
Type 2 diabetes
UKPDS
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims  To examine the proportion of UK Prospective Diabetes Study (UKPDS) patients with Type 2 diabetes taking aspirin regularly for the primary and secondary prevention of cardiovascular disease (CVD) before and after publication of the 1997 American Diabetes Association (ADA) Clinical Practice Recommendations and the 1998 Joint British Recommendations on the Prevention of Coronary Disease in Clinical Practice. Methods  UKPDS annual review data from 1996/7 (n = 3190) and 2000/1 (n = 2467) were used to determine the prevalence of patients taking aspirin regularly in relation to known CVD risk factors and pre‐existing CVD. Results  Patients taking aspirin regularly were more often male than female (24 vs. 20%, P = 0.0033), older (66 ± 8 vs. 62 ± 9 years, P 
ISSN:0742-3071
1464-5491
DOI:10.1111/j.1464-5491.2004.01328.x